|Author (Corporate)||Council of the European Union, European Parliament|
|Series Title||Official Journal of the European Union|
|Series Details||L 291|
On 29 November 2017 the European Commission presented a proposal for a Regulation on the new location of the European Medicines Agency. The European Parliament and the Council of the European Union adopted the Regulation on 14 November 2018.
The European Medicines Agency (EMA) was established by Regulation (EEC) No 2309/93, which was replaced by Regulation (EC) No 726/2004. In accordance with this Regulation the European Medicines Agency was located in London, United Kingdom.
In March 2017 the United Kingdom notified to the European Council its intention to leave the Union. In November 2017, the 27 remaining Member States, in the margins of the General Affairs Council (Art. 50), selected Amsterdam, the Netherlands, as the new seat of the European Medicines Agency.
|Subject Tags||Public Health|
|Keywords||European Medicines Agency [EMA]
|International Organisations||European Union [EU]|